1.Nosocomial Bloodstream Infection in Intensive Care Unit in a General Hospital.
Ki Sook KIM ; Soonduck KIM ; Sunmi JI ; Jesuk LEE
Korean Journal of Epidemiology 2007;29(1):70-79
PURPOSE: Despite of the development of recent medical technology, bloodstream infection (BSI) still has significant influences on mortality and morbidity of patients admitted to the ICU. The BSI has the second most frequent site. Especially BSI in ICU have higher infection rate than general ward. This study was investigated the incidence rate of the nosocomial BSI, risk factors and bacterial pathogens of BSI in ICU for a general hospital. METHODS: This study was carried out for those 443 patients in ICU of general hospital during the period from March 2002 to February 2003. The definition for BSI was based on that of CDC. Data was collected by questionnaire, medical record review. The statistical SPSS(ver. 10.0) was used to analyze data that included chi-square, t-test and logistic regression. RESULTS: In the incidence rates of the BSI were 76.7 in 1,000 per patients, 7.0 in per 1,000 patients days and 32.1 in per 1,000 patients with central lines, 3.2 in per 1,000 cental line days. In the incidence rates of the BSI by type of ICU showed MICU 10.1, SICU 2.9 in per 1,000 patients days. The significant risk factors were identified as type of ICU(OR=5.119, p=0.001), length of stay(OR=1.039, p=0.001). The causal microbes of the BSI were CNS 35.5%, MRSA 23.6%. The bacterial pathogens of central catheter-related BSI were CNS 50%, MRSA 50%. CONCLUSION: The occurrence of ICU-acquired infection was significantly related to the increase in morbidity and mortality. Ongoing targeted surveillance and infection control strategies is necessary to control this problem.
Centers for Disease Control and Prevention (U.S.)
;
Hospitals, General*
;
Humans
;
Incidence
;
Infection Control
;
Intensive Care Units*
;
Critical Care*
;
Logistic Models
;
Medical Records
;
Methicillin-Resistant Staphylococcus aureus
;
Mortality
;
Patients' Rooms
;
Risk Factors
;
Surveys and Questionnaires
2.Association of Visceral Fat Area Measured by InBody 720 with the Results Measured by CT, DEXA and Anthropometric Measurement.
Eun Ji LEE ; Dong Kwan KIM ; SunMi YOO ; Kyu Nam KIM ; Sun Young LEE
Korean Journal of Family Medicine 2010;31(3):190-197
BACKGROUND: Obesity is associated with various chronic diseases, especially abdominal fat affect cardiovascular disease, metabolic disease, diabetes mellitus and mortality. The aim of this study was to estimate the accuracy of the visceral fat area measured by bioelectric impedence analysis (BIA) that easily used in many clinical settings, and to compare with the visceral fat area measured by CT and other abdominal obesity measures. METHODS: Participants were 71 premenopausal adult women whose BMI was over 23 kg/m2. BMI, waist circumference, total abdominal fat area, visceral fat area, subcutaneous fat area by CT and truncal fat by dual-energy X-ray absorptiometry (DEXA) were measured. Visceral fat area measured by Inbody 720 were compared with variables examining abdominal obesity using partial correlation analysis and Bland-Altman analysis. The accuracy of the visceral obesity by BIA was compared with that diagnosed by CT as gold standard. RESULTS: There was significant difference between visceral fat area measured by CT and BIA in women below BMI 30 kg/m2, whereas the difference was not significant in women with BMI > or = kg/m2. Visceral fat area measured by BIA was significantly correlated with visceral fat area measured by CT only in subjects with BMI less than 30 kg/m2 after adjusting for age (r = 0.495, P < 0.01). Bland-Altman plot analysis showed a tendency regardless of BMI status; the more visceral fat area increased, the less the difference between two measures. The sensitivity and the specificity to diagnose visceral obesity by BIA was 50.0%, 81.8% respectively among women with BMI less than 30 kg/m2, and 100.0%, 25.0% respectively among women with BMI > or = 30 kg/m2. CONCLUSION: BIA is not appropriate for evaluation of abdominal visceral obesity.
Abdominal Fat
;
Absorptiometry, Photon
;
Adult
;
Cardiovascular Diseases
;
Chronic Disease
;
Diabetes Mellitus
;
Female
;
Humans
;
Intra-Abdominal Fat
;
Metabolic Diseases
;
Obesity
;
Obesity, Abdominal
;
Sensitivity and Specificity
;
Subcutaneous Fat
;
Waist Circumference
3.Traditional and Genetic Risk Score and Stroke Risk Prediction in Korea
Keum Ji JUNG ; Semi HWANG ; Sunmi LEE ; Hyeon Chang KIM ; Sun Ha JEE
Korean Circulation Journal 2018;48(8):731-740
BACKGROUND AND OBJECTIVES: Whether using both traditional risk factors and genetic variants for stroke as opposed to using either of the 2 alone improves the prediction of stroke risk remains unclear. The purpose of this study was to compare the predictability of stroke risk between models using traditional risk score (TRS) and genetic risk score (GRS). METHODS: We used a case-cohort study from the Korean Cancer Prevention Study-II (KCPS-II) Biobank (n=156,701). We genotyped 72 single nucleotide polymorphisms (SNPs) identified in genome-wide association study (GWAS) on the KCPS-II sub-cohort members and stroke cases. We calculated GRS by summing the number of risk alleles. Prediction models with or without GRS were evaluated in terms of the area under the receiver operating characteristic curve (AUROC). RESULTS: Sixteen out of 72 SNPs identified in GWAS showed significant associations with stroke, with an odds ratio greater than 2.0. For participants aged < 40 years, AUROCs for incident stroke were 0.58, 0.65, and 0.67 in models using modifiable TRS only, GRS only, and TRS plus GRS, respectively, showing that GRS only model had better prediction than TRS only. For participants aged ≥40 years, however, TRS only model had better prediction than GRS only model. Favorable levels of traditional risk were associated with significantly lower stroke risks within each genetic risk category. CONCLUSIONS: TRS and GRS were both independently associated with stroke risk. Using genetic variants in addition to traditional risk factors may be the most accurate way of predicting stroke risk, particularly in relatively younger individuals.
Alleles
;
Epidemiologic Methods
;
Genetics
;
Genome-Wide Association Study
;
Korea
;
Odds Ratio
;
Polymorphism, Single Nucleotide
;
Risk Factors
;
ROC Curve
;
Stroke
4.Traditional and Genetic Risk Score and Stroke Risk Prediction in Korea
Keum Ji JUNG ; Semi HWANG ; Sunmi LEE ; Hyeon Chang KIM ; Sun Ha JEE
Korean Circulation Journal 2018;48(8):731-740
BACKGROUND AND OBJECTIVES:
Whether using both traditional risk factors and genetic variants for stroke as opposed to using either of the 2 alone improves the prediction of stroke risk remains unclear. The purpose of this study was to compare the predictability of stroke risk between models using traditional risk score (TRS) and genetic risk score (GRS).
METHODS:
We used a case-cohort study from the Korean Cancer Prevention Study-II (KCPS-II) Biobank (n=156,701). We genotyped 72 single nucleotide polymorphisms (SNPs) identified in genome-wide association study (GWAS) on the KCPS-II sub-cohort members and stroke cases. We calculated GRS by summing the number of risk alleles. Prediction models with or without GRS were evaluated in terms of the area under the receiver operating characteristic curve (AUROC).
RESULTS:
Sixteen out of 72 SNPs identified in GWAS showed significant associations with stroke, with an odds ratio greater than 2.0. For participants aged < 40 years, AUROCs for incident stroke were 0.58, 0.65, and 0.67 in models using modifiable TRS only, GRS only, and TRS plus GRS, respectively, showing that GRS only model had better prediction than TRS only. For participants aged ≥40 years, however, TRS only model had better prediction than GRS only model. Favorable levels of traditional risk were associated with significantly lower stroke risks within each genetic risk category.
CONCLUSIONS
TRS and GRS were both independently associated with stroke risk. Using genetic variants in addition to traditional risk factors may be the most accurate way of predicting stroke risk, particularly in relatively younger individuals.
5.Smoking-attributable mortality among Korean adults in 2019
Yeun Soo YANG ; Keum Ji JUNG ; Heejin KIMM ; Sunmi LEE ; Sun Ha JEE
Epidemiology and Health 2024;46(1):e2024011-
OBJECTIVES:
Tobacco use ranks among the leading preventable causes of death worldwide. This study was conducted to calculate the mortality rate attributable to smoking in Korea for 2019 and to highlight the importance of tracking and monitoring smoking-related deaths for public health purposes.
METHODS:
Population attributable risk (PAR) was used to estimate the number of deaths related to smoking in 2019. PAR percentages were applied to the estimated mortality figures for various diseases, with PAR determined based on relative risk (RR). Levin’s formula was used to calculate PAR, and RR was adjusted for age and alcohol consumption using Cox proportional hazards regression model to derive disease-specific regression coefficients. The analysis incorporated previously determined smoking rates from 1985, and use rates of novel tobacco products were not considered.
RESULTS:
The findings revealed a total of 67,982 smoking-attributable deaths in Korea in 2019, 56,993 of which occurred in men and 11,049 in women. The PAR of smoking for various causes of death in adult men was highest for lung cancer at 74.9%, followed by pneumonia (29.4%), ischemic heart disease (42.3%), and stroke (30.2%). For women, the PAR for smoking-related death was highest for lung cancer (19.9%), followed by stroke (7.6%), pneumonia (5.7%), and ischemic heart disease (9.1%).
CONCLUSIONS
In countries experiencing rapid fluctuations in smoking rates, including Korea, regular studies on smoking-related mortality is imperative. Furthermore, it is necessary to investigate smoking-related deaths, including the prevalence of novel tobacco product use, to accurately gauge the risks associated with emerging tobacco products.
6.Two-Sample Mendelian Randomization Study of Lipid levels and Ischemic Heart Disease
Su Hyun LEE ; Ji-Young LEE ; Guen hui KIM ; Keum Ji JUNG ; Sunmi LEE ; Hyeon Chang KIM ; Sun Ha JEE
Korean Circulation Journal 2020;50(10):940-948
Background and Objectives:
Associations between blood lipids and risk of ischemic heart disease (IHD) have been reported in observational studies. However, due to confounding and reverse causation, observational studies are influenced by bias, thus their results show inconsistency in the effects of lipid levels on IHD. In this study, we evaluate whether lipid levels have an effect on the risk of IHD in a Korean population.
Methods:
A 2-sample Mendelian randomization (MR) study, using the genetic variants associated with lipid levels as the instrumental variables was performed. Genetic variants significantly associated with lipid concentrations were obtained from the Korean Genome and Epidemiology Study (n=35,000), and the same variants on IHD were obtained from the Korean Cancer Prevention Study-II (n=13,855). Inverse variance weighting (IVW), weighted median, and MR-Egger approaches were used to assess the causal association between lipid levels and IHD. Radial MR methods were applied to remove outliers subject to pleiotropic bias.
Results:
Causal association between low-density lipoprotein-cholesterol (LDL-C) and IHD was observed in the IVW method (odds ratio, 1.013; 95% confidence interval, 1.007–1.109).However, high-density lipoprotein-cholesterol (HDL-C) and triglyceride (TG) did not show causal association with IHD. In the Radial MR analysis of the relationship between HDL-C, TG and IHD, outliers were detected. Interestingly, after removing the outliers, a causal association between TG and IHD was found.
Conclusions
High levels LDL-C and TG were causally associated with increased IHD risk in a Korean population, these results are potentially useful as evidence of a significant causal relationship.
7.Risk Factor and Mortality in Patients with Pulmonary Embolism Combined with Infectious Disease
Gi Dong LEE ; Sunmi JU ; Ju Young KIM ; Tae Hoon KIM ; Jung Wan YOO ; Seung Jun LEE ; Yu Ji CHO ; Yi Yeong JEONG ; Kyung Nyeo JEON ; Jong Deog LEE ; Ho Cheol KIM
Tuberculosis and Respiratory Diseases 2020;83(2):157-166
BACKGROUND: Infectious conditions may increase the risk of venous thromboembolism. The purpose of this study was to evaluate the risk factor for combined infectious disease and its influence on mortality in patients with pulmonary embolism (PE).METHODS: Patients with PE diagnosed based on spiral computed tomography findings of the chest were retrospectively analyzed. They were classified into two groups: patients who developed PE in the setting of infectious disease or those with PE without infection based on review of their medical charts.RESULTS: Of 258 patients with PE, 67 (25.9%) were considered as having PE combined with infectious disease. The sites of infections were the respiratory tract in 52 patients (77.6%), genitourinary tract in three patients (4.5%), and hepatobiliary tract in three patients (4.5%). Underlying lung disease (odds ratio [OR], 3.69; 95% confidence interval [CI], 1.926–7.081; p<0.001), bed-ridden state (OR, 2.84; 95% CI, 1.390–5.811; p=0.004), and malignant disease (OR, 1.867; 95% CI, 1.017–3.425; p=0.044) were associated with combined infectious disease in patients with PE. In-hospital mortality was higher in patients with PE combined with infectious disease than in those with PE without infection (24.6% vs. 11.0%, p=0.006). In the multivariate analysis, combined infectious disease (OR, 4.189; 95% CI, 1.692–10.372; p=0.002) were associated with non-survivors in patients with PE.CONCLUSION: A substantial portion of patients with PE has concomitant infectious disease and it may contribute a mortality in patients with PE.
8.Characteristics and Outcomes of Patients with Pulmonary Acute Respiratory Distress Syndrome Infected with Influenza versus Other Respiratory Viruses
Jung Wan YOO ; Sunmi JU ; Seung Jun LEE ; Min Chul CHO ; Yu Ji CHO ; Yi Yeong JEONG ; Jong Deog LEE ; Ho Choel KIM
Tuberculosis and Respiratory Diseases 2019;82(4):328-334
BACKGROUND: Although the frequency of respiratory viral infection in patients with pulmonary acute respiratory distress syndrome (ARDS) is not uncommon, clinical significance of the condition remains to be further elucidated. The purpose of this study was to compare characteristics and outcomes of patients with pulmonary ARDS infected with influenza and other respiratory viruses. METHODS: Clinical data of patients with pulmonary ARDS infected with respiratory viruses January 2014–June 2018 were reviewed. Respiratory viral infection was identified by multiplex reverse transcription–polymerase chain reaction (RT-PCR). RESULTS: Among 126 patients who underwent multiplex RT-PCR, respiratory viral infection was identified in 46% (58/126): 28 patients with influenza and 30 patients with other respiratory viruses. There was no significant difference in baseline and clinical characteristics between patients with influenza and those with other respiratory viruses. The use of extracorporeal membrane oxygenation (ECMO) was more frequent in patients with influenza than in those with other respiratory viruses (32.1% vs 3.3%, p=0.006). Co-bacterial pathogens were more frequently isolated from respiratory samples of patients with pulmonary ARDS infected with influenza virus than those with other respiratory viruses. (53.6% vs 26.7%, p=0.036). There were no significant differences regarding clinical outcomes. In multivariate analysis, acute physiology and chronic health evaluation II was associated with 30-mortality (odds ratio, 1.158; 95% confidence interval, 1.022–1.312; p=0.022). CONCLUSION: Respiratory viral infection was not uncommon in patients with pulmonary ARDS. Influenza virus was most commonly identified and was associated with more co-bacterial infection and ECMO therapy.
APACHE
;
Extracorporeal Membrane Oxygenation
;
Humans
;
Influenza, Human
;
Multivariate Analysis
;
Orthomyxoviridae
;
Respiratory Distress Syndrome, Adult
9.Interventions to Prevent Catheter-Associated Blood-stream Infections: A Multicenter Study in Korea.
Sunmi YOO ; Sook In JUNG ; Gwang Sook KIM ; Duck Sun LIM ; Jang Wook SOHN ; Jeong Yeon KIM ; Ji Eun KIM ; Yoon Suk JANG ; Sunju JUNG ; Hyunjoo PAI
Infection and Chemotherapy 2010;42(4):216-222
BACKGROUND: The purpose of this study was to determine the efficacy of infection-control interventions to decrease the incidence of catheter-associated bloodstream infections (CA-BSI) and to examine the sustainability of its effect during and after the intervention in Korea. MATERIALS AND METHODS: We conducted a prospective multi-strategy intervention in intensive care units (ICUs) at 3 university hospitals in Korea. The intervention consisted of education and on-site training for medical personnel involved in catheter care, active surveillance, and reinforcement of current intervention in each unit. After the intervention of 3 months, we identified CA-BSI cases of each hospital using the electronic database for 6 months. RESULTS: During the intervention, the number of CA-BSI decreased significantly compared to pre-interventional period (8.7 vs. 2.3 per 1,000 catheter days; rate ratio 0.28; 95% CI, 0.13-0.61). After the intervention, CA-BSI rate increased slightly, but was still significantly lower than that of pre-interventional period (4.3 per 1,000 catheter days; rate ratio, 0.49; 95% CI, 0.31-0.78). Reduction of gram-negative bacterial infections was noted during and after the intervention. CONCLUSIONS: A multi-strategy approach to reduce CA-BSI could be implemented in diverse settings of medical and surgical units in Korea and decreased CA-BSI rates during the intervention.
Catheters
;
Electronics
;
Electrons
;
Gram-Negative Bacterial Infections
;
Hospitals, University
;
Incidence
;
Intensive Care Units
;
Korea
;
Prospective Studies
;
Reinforcement (Psychology)
10.Clinical Impact of Supplementation of Vitamins B1 and C on Patients with Sepsis- Related Acute Respiratory Distress Syndrome
Jung-Wan YOO ; Rock Bum KIM ; Sunmi JU ; Seung Jun LEE ; Yu Ji CHO ; Yi Yeong JEONG ; Jong Deog LEE ; Ho Cheol KIM
Tuberculosis and Respiratory Diseases 2020;83(3):248-254
Background:
Although few studies have reported improved clinical outcomes with the administration of vitamin B1 and C in critically ill patients with septic shock or severe pneumonia, its clinical impact on patients with sepsis-related acute respiratory distress syndrome (ARDS) remains unclear. The purpose of this study was to evaluate the association with vitamin B and C supplementation and clinical outcomes in patients with ARDS.
Methods:
Patients with ARDS requiring invasive mechanical ventilation, admitted to the medical intensive care unit (ICU) were included in this study. Clinical outcomes were compared between patients administered with vitamin B1 (200 mg/day) and C (2 g/day) June 2018–May 2019 (the supplementation group) and those who did not receive vitamin B1 and C administration June 2017–May 2018 (the control group).
Results:
Seventy-nine patients were included. Thirty-three patients received vitamin B1 and C whereas 46 patients did not. Steroid administration was more frequent in patients receiving vitamin B1 and C supplementation than in those without it. There were no significant differences in the mortality between the patients who received vitamin B1 and C and those who did not. There were not significant differences in ventilator and ICU-free days between each of the 21 matched patients.
Conclusion
Vitamin B1 and C supplementation was not associated with reduced mortality rates, and ventilator and ICU-free days in patients with sepsis-related ARDS requiring invasive mechanical ventilation.